Keyword Analysis & Research: sanofi pipeline
Keyword Research: People who searched sanofi pipeline also searched
Search Results related to sanofi pipeline on Search Engine
-
Our Pipeline - Sanofi
https://www.sanofi.com/minisites/pipeline/en/index.html
WEBOur Pipeline. Our determination to find answers for patients and their families motivates us to pursue medicines and vaccines with the greatest potential to improve lives and protect public health. Explore our pipeline.
DA: 88 PA: 39 MOZ Rank: 13
-
Our Healthcare Pipeline - Research, R&D portfolio - Sanofi
https://www.sanofi.com/en/our-science/our-pipeline
WEBFeb 1, 2024 · Our Pipeline. Our determination to find answers for patients and their families motivates us to pursue medicines and vaccines with the greatest potential to improve lives and protect public health. With a strong focus on difficult-to-treat diseases and immunization, our R&D pipeline includes 83 clinical-stage projects, 30 of which are in …
DA: 18 PA: 62 MOZ Rank: 14
-
Press Release: Sanofi Pipeline Transformation to Accelerate …
https://www.sanofi.com/en/media-room/press-releases/2023/2023-12-07-02-30-00-2792186
WEBDec 7, 2002 · Sanofi’s R&D will lead to a 50% increase in the number of Phase 3 studies between 2023 and 2025, creating the greatest pipeline momentum in Sanofi’s history. The company’s commitment to R&D will also support an expected 25 mid- to late-stage read-outs and up to 19 regulatory submissions for its pharma assets in the next two years.
DA: 88 PA: 92 MOZ Rank: 92
-
R&D Focus Areas - Sanofi
https://www.sanofi.com/en/our-science/rd-focus-areas
WEBOur mission is to improve the lives of people everywhere through innovative vaccines and medicines. Discover Sanofi Pharmaceuticals' areas of R&D expertise: our R&D pipeline, technology platforms, data science and much more.
DA: 77 PA: 21 MOZ Rank: 84
-
Sanofi: global healthcare and pharmaceutical company
https://www.sanofi.com/en
WEBMar 21, 2024 · We are an innovative global healthcare company with one purpose: to chase the miracles of science to improve people’s lives.
DA: 36 PA: 44 MOZ Rank: 95
-
R&D Pipeline Registration & Phase 3 - Sanofi
https://www.sanofi.com/assets/dotcom/pages/docs/our-science/our-pipeline/sanofi_q4_2023_pipeline.pdf
WEBR&D Pipeline Registration & Phase 3 Immunology & Inflammation DupixentA Anti-IL-4/IL-13 mAb Bullous Pemphigoid Chronic Pruritus of Unknown Origin Chronic Spontaneous Urticaria Eosinophilic Gastritis itepekimabA Anti-IL-33 mAb Chronic Obstructive Pulmonary Disease amlitelimab Anti-OX40L mAb Atopic Dermatitis Neuro-inflammation tolebrutinib …
DA: 30 PA: 83 MOZ Rank: 38
-
Sanofi to acquire Amunix immuno-oncology pipeline with next …
https://www.sanofi.com/en/media-room/press-releases/2021/2021-12-21-04-30-00-2355740
WEBDecember 21, 2021. Download PDF. Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics. Adds promising pipeline of T-cell engagers and cytokine therapies with lead candidate AMX-818 expected to …
DA: 20 PA: 76 MOZ Rank: 88
-
Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in …
https://www.sanofi.com/assets/dotcom/pressreleases/2024/2024-04-23-05-00-00-2867327-en.pdf
WEB1 day ago · immunology pipeline and a testament to Sanofi’s ability to successfully accelerate and build a portfolio of next-generation transformative treatments for immune diseases • In addition to ITP, rilzabrutinib is being studied across a variety of immune-mediated diseases including asthma, chronic spontaneous urticaria, prurigo nodularis, …
DA: 3 PA: 72 MOZ Rank: 6
-
Sanofi Pipeline Transformation to Accelerate Growth Driven by …
https://www.pharmiweb.com/pwtoday-story/sanofi-pipeline-transformation-to-accelerate-growth-driven-by-record-number-of-potential-blockbuster-launches-paving-the-way-to-industry-leadership-in-immunology
WEBDec 8, 2023 · Sanofi’s R&D will lead to a 50% increase in the number of Phase 3 studies between 2023 and 2025, creating the greatest pipeline momentum in Sanofi’s history. The company’s commitment to R&D will also support an expected 25 mid- to late-stage read-outs and up to 19 regulatory submissions for its pharma assets in the next two years.
DA: 78 PA: 23 MOZ Rank: 86
-
Biotech mega-deals boost Pfizer, Sanofi pipelines - Nature
https://www.nature.com/articles/s41587-023-01761-4
WEBApr 17, 2023 · Biotech mega-deals boost Pfizer, Sanofi pipelines. Nature Biotechnology 41 , 439 ( 2023) Cite this article. 1067 Accesses. 2 Altmetric. Metrics. Pfizer and Sanofi have each made...
DA: 54 PA: 74 MOZ Rank: 15
